Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
First human tests begin for new asthma and COPD treatment
Disease control OngoingThis is the first study testing a new drug called GB-0895 in people. Researchers want to see if it's safe and how the body handles it in adults with mild to moderate asthma or COPD. The study will involve 156 participants and will test different doses to find the right amount tha…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
First humans test new eczema shot in early safety trial
Knowledge-focused OngoingThis is the first-ever study in humans of a new drug called GB-7624, which is being developed for atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. The study will enroll 40 healthy adult volunteers to receive either the drug …
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC